Frauenheilkunde up2date, Table of Contents Frauenheilkunde up2date 2014; 8(4): 239-250DOI: 10.1055/s-0033-1357978 Allgemeine Gynäkologie und gynäkologische Onkologie Georg Thieme Verlag KG Stuttgart · New YorkVulvakarzinom: primäre und adjuvante Therapie Authors Sven Mahner Lisa Wagner Fabian Trillsch Donata Grimm Fritz Jänicke Cordula Petersen Linn Wölber Recommend Article Abstract Buy Article(opens in new window) All articles of this category(opens in new window) Full Text References Literatur 1 Beller U, Quinn M, Benedet J et al. Carcinoma of the vulva. FIGO 26th Annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2006; 95 (Suppl. 01) S7-S27 2 Judson P, Habermann E, Baxter N et al. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol 2006; 107: 1018-1022 3 Madsen B, Jensen H, van den Brule A et al. Risk factors for invasive squamous cell carcinoma of the vulva and vagina – population-based case-control study in Denmark. Int J Cancer 2008; 122: 2827-2834 4 Messing M, Gallup D. Carcinoma of the vulva in young women. Obstet Gynecol 1995; 86: 51-54 5 Gadducci A, Cionini L, Romanini A et al. Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer. Crit Rev Oncol Hematol 2006; 60: 227-241 6 Woelber L, Mahner S, Voelker K et al. Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer. Anticancer Res 2009; 29: 545-552 7 Lin J, DuBeshter B, Angel C et al. Morbidity and recurrence with modifications of radical vulvectomy and groin dissection. Gynecol Oncol 1992; 47: 80-86 8 Magrina J, Gonzalez-Bosquet J, Weaver A et al. Primary squamous cell cancer of the vulva: radical versus modified radical vulvar surgery. Gynecol Oncol 1998; 71: 116-121 9 Byron S, Lamb E, Yonemoto R et al. Radical inguinal node dissection in the treatment of cancer. Surg Gynecol Obstet 1962; 114: 401-408 10 Siller B, Alvarez R, Conner W et al. T2/3 vulva cancer: a case-control study of triple incision versus en bloc radical vulvectomy and inguinal lymphadenectomy. Gynecol Oncol 1995; 57: 335-339 11 Ansink A, van der Velden J. Surgical interventions for early squamous cell carcinoma of the vulva. Cochrane Database Syst Rev 2000; (2) CD002036 12 Heaps J, Fu Y, Montz F et al. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 1990; 38: 309-314 13 Olawaiye A, Lee L, Krasner C, Neil H. Treatment of squamous cell vulvar cancer with the anti-EGFR tyrosine kinase inhibitor Tarceva. Gynecol Oncol 2007; 106: 628-630 14 Burke T, Levenback C, Coleman R et al. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol 1995; 97: 215-220 15 Farias-Eisner R, Cirisano F, Grouse D et al. Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T1-2N0-1M0) disease. Gynecol Oncol 1994; 53: 55-58 16 DiSaia P, Creasman W, Rich W. An alternate approach to early cancer of the vulva. Am J Obstet Gynecol 1979; 133: 825-832 17 Hampl M, Kueppers V, Bender H. Single large inguinal lymph node metastasis in human papillomavirus-induced early invasive vulvar cancer of the anterior fourchette in two young women. Gynecol Obstet Invest 2009; 67: 42-45 18 Kunos C, Simpkins F, Gibbons H et al. Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial. Obstet Gynecol 2009; 114: 537-546 19 Wittekind C, Meyer H eds. TNM Klassifikation maligner Tumoren. New York: Wiley VCH; 2002 20 Woelber L, Choschzick M, Eulenburg C et al. Prognostic value of pathological resection margin distance in squamous cell cancer of the vulva. Ann Surg Oncol 2011; 18: 3811-3818 21 Kelley III J, Burke T, Tornos C et al. Minimally invasive vulvar carcinoma: an indication for conservative surgical therapy. Gynecol Oncol 1992; 44: 240-244 22 Magrina J, Webb M, Gaffey T et al. Stage I squamous cell cancer of the vulva. Am J Obstet Gynecol 1979; 134: 453-459 23 Sidor J, Diallo-Danebrock R, Eltze E et al. Challenging the concept of microinvasive carcinoma of the vulva: report of a case with regional lymph node recurrence and review of the literature. BMC Cancer 2006; 6: 157 24 Homesley H, Bundy B, Sedlis A et al. Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecologic Oncology Group study). Gynecol Oncol 1993; 49: 279-283 25 Bell J, Jayanthi S, Reid G. Complete groin lymphadenectomy with preservation of the fascia lata in the treatment of vulvar carcinoma. Gynecol Oncol 2000; 77: 314-318 26 Gaarenstroom K, Kenter G, Trimbos J et al. Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int J Gynecol Cancer 2003; 13: 522-527 27 Rouzier R, Haddad B, Plantier F et al. Local relapse in patients treated for squamous cell vulvar carcinoma: incidence and prognostic value. Obstet Gynecol 2002; 100: 1159-1167 28 Woelber L, Mahner S, Voelker C et al. Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer. Anticancer Res 2009; 29: 545-552 29 Levenback C, Burke T, Gershenson D et al. Intraoperative lymphatic mapping for vulvar cancer. Obstet Gynecol 1994; 84: 163-167 30 De Cicco C, Sideri M, Bartolomei M et al. Sentinel node biopsy in early vulvar cancer. Br J Cancer 2000; 82: 295-299 31 Sliutz G, Reinthaller A, Lantzsch T et al. Lymphatic mapping of sentinel nodes in early vulvar cancer. Gynecol Oncol 2002; 84: 449-452 32 van der Zee A, Oonk M, Hullu J et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 2008; 26: 884-889 33 Hacker N, Berek J, Lagasse L et al. Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet Gynecol 1983; 61: 408-412 34 Rodolakis A, Diakomanolis E, Voulgaris Z et al. Squamous vulvar cancer: a clinically based individualization of treatment. Gynecol Oncol 2000; 78: 346-351 35 Han S, Kim D, Higgins S et al. Chemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva. Int J Radiat Oncol Biol Phys 2000; 47: 1235-1244 36 Andrews S, Williams B, DePriest P et al. Therapeutic implications of lymph nodal spread in lateral T1 and T2 squamous cell carcinoma of the vulva. Gynecol Oncol 1994; 55: 41-46 37 Farias-Eisner R, Cirisano F, Grouse D et al. Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T1-2N0-1M0) disease. Gynecol Oncol 1994; 53: 55-58 38 Bundy B, Dvoretsky P, Creasman W. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol 1992; 49: 490-497 39 Woelber L, Eulenburg C, Choschzick M et al. Prognostic role of lymph node metastases in vulvar cancer and implications for adjuvant treatment. Int J Gynecol Cancer 2012; 22: 503-508 40 Levenback C, Morris M, Burke T et al. Groin dissection practices among gynecologic oncologists treating early vulvar cancer. Gynecol Oncol 1996; 62: 73-77 41 Micheletti L, Borgno G, Barbero M et al. Deep femoral lymphadenectomy with preservation of the fascia lata. Preliminary report on 42 invasive vulvar carcinomas. J Reprod Med 1990; 35: 1130-1133 42 Gaarenstroom K, Kenter G, Trimbos J et al. Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int J Gynecol Cancer 2003; 13: 522-527 43 Rouzier R, Haddad B, Plantier F et al. Local relapse in patients treated for squamous cell vulvar carcinoma: incidence and prognostic value. Obstet Gynecol 2002; 100: 1159-1167 44 Homesley H, Bundy B, Sedlis A et al. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 1986; 68: 733-740 45 Mahner S, Jueckstock J, Hilpert F et al. Impact of adjuvant therapy in lymph-node positive vulvar cancer: The AGO CARE 1 study. J Clin Oncol 2012; 30 (Suppl.) abstract 5007 46 Curry S, Taylor Wharton J, Felix R. Positive lymph nodes in vulvar squamous carcinoma. Gynecol Oncol 1980; 9: 63-67 47 Hacker N, Berek J, Lagasse L et al. Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet Gynecol 1983; 61: 408-412 48 de Hullu J, van der Zee A. Surgery and radiotherapy in vulvar cancer. Crit Rev Oncol Hematol 2006; 60: 38-58 49 Burger M, Hollema H, Emanuels A et al. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol 1995; 57: 327-334 50 Bellati F, Angioli R, Manci N et al. Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases. Gynecol Oncol 2005; 96: 227-231 51 Thornton jr. W, Flanagan jr. W. Pelvic exenteration in the treatment of advanced malignancy of the vulva. Am J Obstet Gynecol 1973; 117: 774-781 52 Hockel M, Dornhofer N. Vulvovaginal reconstruction for neoplastic disease. Lancet Oncol 2008; 9: 559-568 53 Weikel W, Hofmann M, Steiner E et al. Reconstructive surgery following resection of primary vulvar cancers. Gynecol Oncol 2005; 99: 92-100 54 Slevin N, Pointon R. Radical radiotherapy for carcinoma of the vulva. Br J Radiol 1989; 62: 145-147 55 Pohar S, Hoffstetter S, Peiffert D et al. Effectiveness of brachytherapy in treating carcinoma of the vulva. Int J Radiat Oncol Biol Phys 1995; 32: 1455-1460 56 Sharma D, Rath G, Kumar S et al. Treatment outcome of patients with carcinoma of vulva: experience from a tertiary cancer center of India. J Cancer Res Ther 2010; 6: 503-507 57 Hoffman M. Squamous-cell carcinoma of the vulva: locally advanced disease. Best Pract Res Clin Obstet Gynaecol 2003; 17: 635-647 58 Moore D, Thomas G, Montana G et al. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys 1998; 42: 79-85 59 Moore D, Ali S, Koh W et al. A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study. Gynecol Oncol 2012; 124: 529-533 60 Tans L, Ansink A, van Rooij P et al. The role of chemo-radiotherapy in the management of locally advanced carcinoma of the vulva: single institutional experience and review of literature. Am J Clin Oncol 2010; 34: 22-26 61 van Doorn H, Ansink A, Verhaar-Langereis M et al. Neoadjuvant chemoradiation for advanced primary vulvar cancer. Cochrane Database Syst Rev 2006; (3) CD003752 62 Cormio G, Loizzi V, Gissi F et al. Cisplatin and vinorelbine chemotherapy in recurrent vulvar carcinoma. Oncology 2009; 77: 281-284 63 Wagenaar H, Colombo N, Vergote I et al. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. Gynecol Oncol 2001; 81: 348-354 64 Witteveen P, van der Velden J, Vergote I et al. Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer–Gynaecological Cancer Group). Ann Oncol 2009; 20: 1511-1516 65 Monk B, Sill M, McMeekin D et al. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 2009; 27: 4649-4655 66 Horowitz N, Olawaiye A, Borger D et al. Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva. Gynecol Oncol 2012; 127: 141-146 67 Sobin LH, Gospodarowicz M, Wittekind C. Vulva. TNM Online 2010; 197-201
